Menu
News
Ibogaine
Ketamine
LSD
MDMA
Psilocybin
Resources
Research Hubs
Studies and Reports
Provider Directory
Terminology
Opinion
Events
About Us
John Scott
BetterLife Pharma Set to Begin Human Trials for LSD Derivative
May 3, 2024
Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm
April 26, 2024
MORE HEADLINES
Psilocybin Clinical Trial for Mental-Health Workers Approved in Canada
May 24, 2024
Psilocybin Spurs Dynamic Brain ‘Hyperconnectivity’ Linked to Psychedelic Epiphanies
May 24, 2024
AbbVie, Gilgamesh to Collaborate on Development of Novel Neuroplastogens
May 22, 2024
Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD
May 17, 2024
BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle
May 15, 2024
1
2
3
4
›
»
CATEGORIES
Psilocybin
MDMA
LSD
Ketamine
